Laurus Labs Share Price Hits Fresh 52-Week High at Rs 1,981: Key Reasons Behind the Rally
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Laurus Labs Share Price moved to Rs 1,970.15 on 18 September 2026, up Rs 13.75 or 0.70% from the previous close, after touching a fresh 52-week high of Rs 1,981.25. The company’s market capitalisation stands at Rs 1,02,983.51 crore, placing the latest update firmly in focus for Laurus Labs stock news and Laurus Labs Share Price Today watchers.
The supplied data confirms the price event but does not establish a company-specific catalyst. Even so, the fresh 52-week high makes Laurus Labs Share Price relevant for market participants tracking one-year high stocks, especially because the move comes alongside a large market capitalisation, a high valuation profile and a sector backdrop that can be compared with listed pharma peers. Univest is tracking the event as part of its Laurus Labs Share Price Live coverage.
For readers searching Laurus Labs Stock News, Laurus Labs News Today or Laurus Labs Share News, the key facts are straightforward: the stock opened at Rs 1,960, traded between Rs 1,960 and Rs 1,981.25, and finished above the previous close. Univest is treating this as a fresh 52-week high update, not as an all-time high claim.
Laurus Labs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,970.15 |
| Previous Close | Rs 1,956.4 |
| Today's Move | +Rs 13.75 (+0.7%) |
| Open | Rs 1,960 |
| High | Rs 1,981.25 |
| Low | Rs 1,960 |
| Turnover | Rs 5.67 crore |
| Market Capitalisation | Rs 1,02,983.51 crore |
Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,970.15 versus the previous close of Rs 1,956.4, a rise of 0.7%. The stock opened at Rs 1,960, reached a high of Rs 1,981.25 and touched a low of Rs 1,960.
Laurus Labs Share Price Today shows a clean day-over-day advance of Rs 13.75 from Rs 1,956.40 to Rs 1,970.15. The day’s high of Rs 1,981.25 matched the reported 52-week high, while the low stayed at Rs 1,960 and the stock closed close to the day’s upper end. Turnover for the session was Rs 5.67 crore.
That combination of current price, previous close, day open and day range gives a precise view of the session without adding any unverified explanation. Because the supplied data identifies the fresh 52-week high, the move is relevant for Laurus Labs Share Price Today searches, Laurus Labs Share Price Update queries and Laurus Labs Stock Analysis readers who want the day’s factual price behaviour.
In simple terms, Laurus Labs Share Price has pushed to a yearly high, and the market data available here confirms the event while stopping short of assigning a cause. The next section matters because investors typically connect a stock’s price action with its valuation, profitability and balance-sheet quality.
Univest is using the price update to frame the stock in a wider research context, not to infer a trigger. That keeps the Laurus Labs Share Price story anchored in verified market data.
Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,02,983.51 crore |
| P/E Ratio | 96.68x |
| P/B Ratio | 18.75x |
| ROE | 18.31% |
| ROCE | 18.2% |
| EPS | Rs 20.24 |
| Book Value Per Share | Rs 104.37 |
| Dividend Yield | 0.1% |
Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 96.68x, P/B 18.75x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.
Laurus Labs Ltd. has a market capitalisation of Rs 102983.51 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 96.68x, P/B at 18.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.53x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 96.68x |
| Benchmark Median P/E | 32.53x |
| Benchmark Average P/E | 44.41x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 18.75x |
| Benchmark Median P/B | 3.09x |
| Company ROE | 18.31% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 18.2% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 1,02,983.51 crore |
| Benchmark Median Market Cap | Rs 733.35 crore |
Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 96.68x, which is above the benchmark median of 32.53x, a difference of +197.2%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.74%, a difference of +55.96%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.63%, a difference of +33.53%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 95,591.76 | 30.36 | 2.56 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 94,419.51 | 26.1 | 2.49 | 9.93 | 12.76 |
| Lupin Ltd. | LUPIN | 93,611.47 | 17.3 | 4.02 | 27.11 | 28.86 |
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 96.68x compared with the displayed peer median of 26.1x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 16%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,02,983.51 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Laurus Labs
- Laurus Labs Share Price touched a fresh 52-week high of Rs 1,981.25.
- The stock closed at Rs 1,970.15, Rs 13.75 above the previous close.
- Turnover for the session was Rs 5.67 crore.
- P/E is 96.68 and P/B is 18.75 on the supplied data.
- Revenue and net profit both rose in the latest company financials supplied here.
About Laurus Labs
Laurus Labs Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data identifies the company within the listed Indian market under NSE and BSE coverage, with Laurus Labs Share Price tracked as a market event in the same sector and industry framework used for comparison.
Univest uses this classification to place Laurus Labs Stock News alongside other Indian Stock Market updates. For readers following Laurus Labs Share Price Today, the company context here is limited to the verified sector and industry labels supplied in the data.
Track Laurus Labs Share Price on Univest
Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Laurus Labs Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. The platform also helps readers compare Laurus Labs Stock News with sector and peer context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Laurus Labs Share Price today?
Ans. Laurus Labs Share Price today is Rs 1,970.15, up Rs 13.75 or 0.70% from the previous close of Rs 1,956.40. The session also set a fresh 52-week high at Rs 1,981.25.
Did Laurus Labs touch a fresh 52-week high?
Ans. Yes. Laurus Labs Share Price hit a fresh 52-week high of Rs 1,981.25, while the stock closed at Rs 1,970.15. The event is significant for readers tracking Laurus Labs Stock News and one-year high updates.
What does Laurus Labs Share Price tell investors today?
Ans. Laurus Labs Share Price shows a higher close than the previous session and a market capitalisation of Rs 1,02,983.51 crore. The move is a verified price event, not a disclosed company-specific catalyst.
How are Laurus Labs valuation metrics reading?
Ans. Laurus Labs Share Price is trading with a P/E of 96.68 and a P/B of 18.75. EPS is Rs 20.24 and book value per share is Rs 104.37, while dividend yield is 0.1%.
How does Laurus Labs compare with pharma peers?
Ans. Laurus Labs Share Price carries a higher P/E and P/B than the supplied pharma peers, while market capitalisation is close to Cipla and Zydus Lifesciences. ROE and ROCE are above several peers in the set.
What sector does Laurus Labs belong to?
Ans. Laurus Labs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector framing is useful for Laurus Labs Share Price readers comparing the stock with the supplied industry benchmark and peer set.
